FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

2836411000001102: Durogesic 50 transdermal patches (Janssen-Cilag Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17226701000001119 Durogesic 50 transdermal patches (Janssen-Cilag Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
68006201000001112 Durogesic 50micrograms transdermal patches (Janssen-Cilag Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Durogesic 50 transdermal patches (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Durogesic 50 transdermal patches (Janssen-Cilag Ltd) Is a Fentanyl 50micrograms/hour patch false Inferred relationship Existential restriction modifier
Durogesic 50 transdermal patches (Janssen-Cilag Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Durogesic 50 transdermal patches (Janssen-Cilag Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Durogesic 50 transdermal patches (Janssen-Cilag Ltd) Has active ingredient Fentanyl true Inferred relationship Existential restriction modifier
Durogesic 50 transdermal patches (Janssen-Cilag Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Durogesic 50 transdermal patches (Janssen-Cilag Ltd) VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Durogesic 50 transdermal patches (Janssen-Cilag Ltd) Has manufactured dose form Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Durogesic 50 transdermal patches (Janssen-Cilag Ltd) Is a Durogesic true Inferred relationship Existential restriction modifier
Durogesic 50 transdermal patches (Janssen-Cilag Ltd) Has specific active ingredient Fentanyl true Inferred relationship Existential restriction modifier
Durogesic 50 transdermal patches (Janssen-Cilag Ltd) Has dispensed dose form Prolonged-release transdermal patch true Inferred relationship Existential restriction modifier
Durogesic 50 transdermal patches (Janssen-Cilag Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Durogesic 50 transdermal patches (Janssen-Cilag Ltd) Is a Fentanyl 50micrograms/hour transdermal patches false Inferred relationship Existential restriction modifier
Durogesic 50 transdermal patches (Janssen-Cilag Ltd) Is a Fentanyl 50micrograms/hour transdermal patches true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Durogesic 50 transdermal patches (Janssen-Cilag Ltd) 5 patch Is pack of False Durogesic 50 transdermal patches (Janssen-Cilag Ltd) Inferred relationship Existential restriction modifier
Durogesic 50 transdermal patches (Janssen-Cilag Ltd) 5 patch Has AMP True Durogesic 50 transdermal patches (Janssen-Cilag Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start